By Aveluro Research Team · Editorial policy
MED (MED) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 18,400 VND, little changed on the session, giving a market capitalization of 228.3 billion VND.
On valuation, MED trades at a price-to-earnings ratio of 11.7 and a price-to-book of 0.7. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 5.8% points to weak profitability relative to the company's equity base, below the sector average of 10.4%. Trailing earnings per share stand at 1,578 VND.
Aveluro tracks 2 news items mentioning MED, where recent coverage skews negative (100% of articles). The most recent catalyst was a regulation change event — "HNX Removes 58 Stocks from Margin Trading Eligibility for Q3 2026". Aveluro's composite model rates MED 8.1/10 (Strong Buy), blending news sentiment, price momentum, and fundamentals.
Average daily volume over the past 10 sessions is roughly 1,271 shares; liquidity is relatively thin, so single headlines can move the price sharply. Comparable names in the Health Care sector include AGP, AMV and APC.
What matters now
HNX Removes 58 Stocks from Margin Trading Eligibility for Q3 2026
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.